Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Oncology|October 12, 2023
Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors: A Systematic ReviewAnjali Kulkarni, Carly Cooke, Rouhi Fazelzad, et al.
Gynecologic Oncology|November 10, 2021
Secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma: A systematic review and meta-analysisRebecca M Goldberg, Soyoun Rachel Kim, Rouhi Fazelzad, et al.
Transplantation and Cellular Therapy|January 23, 2026
Impact of pretransplant blinatumomab on post-transplant outcomes in B-cell acute lymphoblastic leukemia: a systematic review and meta-analysisSergio Rodriguez-Rodriguez, Anna Olive, Fausto Alfredo Rios-Olais, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2021
Contemporary dose-escalation methods for early phase studies in the immunotherapeutics eraDaniel V Araujo, Marc Oliva, Kecheng Li, et al.
Cancer Treatment Reviews|July 23, 2017
Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancerHadar Goldvaser, Domen Ribnikar, Rouhi Fazelzad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 25, 2016
Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatmentSchroder Sattar, Shabbir M H Alibhai, Sandra L Spoelstra, et al.
Eclinicalmedicine|March 30, 2026
Predictors of response to compression therapy in breast cancer-related lymphoedema: a systematic review and meta-analysisEnoch Yu, Nicholas Lum, Salvan Hassan, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2016
A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid CancerYong Gyu Hyun, Ahmad Alhashemi, Rouhi Fazelzad, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic ReviewCaitlin Lazurko, Revital Linder, Kate Pulman, et al.
Molecular Diagnosis & Therapy|February 2, 2022
Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-AnalysisRamy R Saleh, Jordan L Scott, Nicholas Meti, et al.
Pageof 8